|
|
HYPROMELLOSE 2208 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
FUMARIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
GLYXAMBI Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
HISTIDINE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
GLYCERYL MONOSTEARATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|